AlphaGene's
greatest single asset is having one of the largest, physical inventories of full-length human
genes (See Gene Inventory). AlphaGene produces gene
libraries containing very large quantities (and high percentages) of full-length
cDNAs which include complete protein encoding sequences.
AlphaGene
is a privately held - functional genomics company offering products and
services to biotech and pharmaceutical companies engaged in drug discovery
and development. AlphaGene uses its large inventory of full-length, novel cDNAs
and bioinformatics expertise to bridge the gap between genomics and
functional proteomics. The company focuses on differential gene expression
to identify potential drug targets, primarily for oncological and serious degenerative neurological diseases.
AlphaGene's business strategy
is directed at the integration of state-of-the-art genomics technologies to
enable biotechnology and pharmaceutical partners to accelerate and improve the
drug discovery process.
